Literature DB >> 18975076

Detection of Helicobacter pylori in paraffin-embedded specimens from patients with chronic liver diseases, using the amplification method.

Tahereh Pirouz1, Leila Zounubi, Hussein Keivani, Nasser Rakhshani, Mahshid Hormazdi.   

Abstract

Helicobacter DNA has been detected in the liver specimens of patients with various hepato-biliary diseases. The aim of this study was to investigate the presence of H. pylori DNA in the liver tissue of Iranian patients with chronic liver diseases (CLD). Genomic DNA was extracted from the paraffin sections of 46 liver biopsies of patients with CLD and 13 from patients with metastatic adenocarcinoma as a control group. Polymerase chain reaction (PCR) analysis was carried out using primers for H. pylori 16S rRNA and cagA genes. On analysis, 17 of the 46 patient samples were positive in H. pylori 16S rRNA PCR and 2 of the 13 were positive from the control group. None of the samples were positive for the cagA gene. This study showed the greater presence of H. pylori-like DNA in the liver samples from patients with CLD than in controls.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18975076     DOI： 10.1007/s10620-008-0522-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


  29 in total

1.  Prevalence of Helicobacter pullorum among patients with gastrointestinal disease and clinically healthy persons.

Authors:  Liesbeth Ceelen; Annemie Decostere; Gerda Verschraegen; Richard Ducatelle; Freddy Haesebrouck
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

2.  Detection of Helicobacter species in liver and stomach tissues of patients with chronic liver diseases using polymerase chain reaction-denaturing gradient gel electrophoresis and immunohistochemistry.

Authors:  Piotr Stalke; Waleed Abu Al-Soud; Krzysztof P Bielawski; Alicja Bakowska; Hanna Trocha; Jan Stepinski; Torkel Wadström
Journal:  Scand J Gastroenterol       Date:  2005-09       Impact factor: 2.423

3.  Helicobacter bilis-induced inflammatory bowel disease in scid mice with defined flora.

Authors:  N H Shomer; C A Dangler; M D Schrenzel; J G Fox
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

4.  Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma.

Authors:  P Avenaud; A Marais; L Monteiro; B Le Bail; P Bioulac Sage; C Balabaud; F Mégraud
Journal:  Cancer       Date:  2000-10-01       Impact factor: 6.860

5.  Association of the presence of Helicobacter in gallbladder tissue with cholelithiasis and cholecystitis.

Authors:  Cíntia Presser Silva; Júlio Carlos Pereira-Lima; Adriana Gonçalves Oliveira; Juliana Becattini Guerra; Daniela Lemos Marques; Letícia Sarmanho; Mônica Maria Demas Alvares Cabral; Dulciene Maria Magalhães Queiroz
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

Review 6.  Extragastric manifestations of Helicobacter pylori infection -- other Helicobacters.

Authors:  Ulrich R M Bohr; Bruno Annibale; Francesco Franceschi; Davide Roccarina; Antonio Gasbarrini
Journal:  Helicobacter       Date:  2007-10       Impact factor: 5.753

7.  Topographical localisation of cagA positive and cagA negative Helicobacter pylori strains in the gastric mucosa; an in situ hybridisation study.

Authors:  M Camorlinga-Ponce; C Romo; G González-Valencia; O Muñoz; J Torres
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

8.  Helicobacter pylori may play a contributory role in the pathogenesis of primary sclerosing cholangitis.

Authors:  Alyssa M Krasinskas; Yuan Yao; Parmjeet Randhawa; Maria P Dore; Antonia R Sepulveda
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

9.  Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class.

Authors:  L J Murray; K B Bamford; D P O'Reilly; E E McCrum; A E Evans
Journal:  Br Heart J       Date:  1995-11

Review 10.  Helicobacter pylori infection and respiratory diseases: a review.

Authors:  Anastasios Roussos; Nikiforos Philippou; Konstantinos I Gourgoulianis
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742
View more
  20 in total

Review 1.  Flagellin glycosylation with pseudaminic acid in Campylobacter and Helicobacter: prospects for development of novel therapeutics.

Authors:  Abu Iftiaf Md Salah Ud-Din; Anna Roujeinikova
Journal:  Cell Mol Life Sci       Date:  2017-10-27       Impact factor: 9.261

Review 2.  The Association Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease.

Authors:  Derek M Tang; Sheila Kumar
Journal:  Curr Gastroenterol Rep       Date:  2017-02

3.  Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease.

Authors:  Yoshio Sumida; Kazuyuki Kanemasa; Shunsuke Imai; Kojiro Mori; Saiyu Tanaka; Hideto Shimokobe; Yoko Kitamura; Kohei Fukumoto; Akira Kakutani; Tomoyuki Ohno; Hiroyoshi Taketani; Yuya Seko; Hiroshi Ishiba; Tasuku Hara; Akira Okajima; Kanji Yamaguchi; Michihisa Moriguchi; Hironori Mitsuyoshi; Kohichiroh Yasui; Masahito Minami; Yoshito Itoh
Journal:  J Gastroenterol       Date:  2015-01-28       Impact factor: 7.527

4.  Strategies for gastric cancer in the modern era.

Authors:  Satoru Takayama; Takehiro Wakasugi; Hitoshi Funahashi; Hiromitsu Takeyama
Journal:  World J Gastrointest Oncol       Date:  2010-09-15

Review 5.  From the stomach to other organs: Helicobacter pylori and the liver.

Authors:  Marek Waluga; Michał Kukla; Michał Żorniak; Agata Bacik; Rafał Kotulski
Journal:  World J Hepatol       Date:  2015-08-28

Review 6.  Extragastric manifestations of Helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases.

Authors:  Elizabeth Ma Rabelo-Gonçalves; Bruna M Roesler; José Mr Zeitune
Journal:  World J Hepatol       Date:  2015-12-28

Review 7.  Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease.

Authors:  Meng Li; Zhe Shen; You-Ming Li
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

8.  The effect of helicobacter pylori eradication on liver fat content in subjects with non-alcoholic Fatty liver disease: a randomized open-label clinical trial.

Authors:  Raika Jamali; Alireza Mofid; Homayoon Vahedi; Rojin Farzaneh; Shahab Dowlatshahi
Journal:  Hepat Mon       Date:  2013-12-06       Impact factor: 0.660

9.  Structural and functional characterization of the Helicobacter pylori cytidine 5'-monophosphate-pseudaminic acid synthase PseF: molecular insight into substrate recognition and catalysis mechanism.

Authors:  Syeda Umme Habiba Wahid
Journal:  Adv Appl Bioinform Chem       Date:  2017-10-06

Review 10.  Virulence Factors of Helicobacter pylori: A Review.

Authors:  Bruna M Roesler; Elizabeth M A Rabelo-Gonçalves; José M R Zeitune
Journal:  Clin Med Insights Gastroenterol       Date:  2014-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.